NYSE:GLS Gelesis - GLS News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Gelesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.16 -0.01 (-4.91%) (As of 03/24/2023 02:15 PM ET) Add Compare Share Share Today's Range$0.14▼$0.1750-Day Range$0.11▼$0.4052-Week Range$0.11▼$6.19Volume166,346 shsAverage Volume384,588 shsMarket Capitalization$11.46 millionP/E RatioN/ADividend YieldN/APrice Target$1.15 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Gelesis News Delivered to You Automatically Sign up to receive the latest news and ratings for GLS and its competitors with MarketBeat's FREE daily newsletter. Email Address GLS Media Mentions By Week GLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLS News Sentiment▼0.170.36▲Average Medical News Sentiment GLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLS Articles This Week▼30▲GLS Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGelesis (GLS) Set to Announce Earnings on Wednesdayamericanbankingnews.com - March 21 at 9:06 AMGelesis (GLS) Scheduled to Post Earnings on Wednesdayamericanbankingnews.com - March 21 at 8:15 AMGLS Gelesis Holdings, Inc.seekingalpha.com - January 27 at 6:15 PMGelesis to Participate in the 25th Annual ICR Conferencefinance.yahoo.com - January 5 at 7:59 AMNYSE to Suspend Trading Immediately in Warrants of Gelesis Holdings, Inc. (GLS WS) and Commence Delisting Proceedingstechnews.tmcnet.com - January 4 at 8:15 PMGelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conferencefinance.yahoo.com - November 21 at 12:07 PMGelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliancefinance.yahoo.com - November 18 at 8:08 PMGelesis Holdings, Inc. (GLS) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 14 at 7:35 PMGelesis Reports Third Quarter 2022 Resultsfinance.yahoo.com - November 14 at 10:22 AMGelesis to Report Third Quarter 2022 Financial Results on November 14, 2022finance.yahoo.com - November 7 at 8:43 AMGelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliancefinance.yahoo.com - November 4 at 7:55 PMData Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebioticsfinance.yahoo.com - November 2 at 7:09 PMDr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Weekfinance.yahoo.com - November 1 at 6:48 PMInvestors in Gelesis Holdings (NYSE:GLS) have unfortunately lost 89% over the last yearca.finance.yahoo.com - October 5 at 9:30 AMGelesis Holdings Inc GLS Stock Analysismorningstar.com - September 9 at 10:56 PMGelesis to Participate in the Jefferies Virtual Fitness & Wellness Summitfinance.yahoo.com - September 8 at 11:53 AMClinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndromefinance.yahoo.com - August 25 at 9:47 AMInvestors one-year losses grow to 89% as the stock sheds US$21m this past weeknasdaq.com - August 24 at 10:04 AMREPLAY: Fight Obesity With Biotech – Gelesis CEO, CFO in Fireside Chatfinance.yahoo.com - August 17 at 8:09 PMAnalyzing Gelesis Holdings Short Interestmsn.com - August 17 at 3:05 PMGelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ETfinance.yahoo.com - August 17 at 10:04 AMArming Consumers to Fight Obesity with Biotech – Join CEO and CFO of Gelesis in Fireside Chat Wednesday at 2 ETfinance.yahoo.com - August 16 at 1:58 PMGelesis Holdings, Inc. (GLS) CEO Yishai Zohar on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 15 at 5:25 PMGelesis Reports Second Quarter 2022 Resultsfinance.yahoo.com - August 15 at 5:25 PMGelesis to Report Second Quarter 2022 Financial Results on August 15, 2022finance.yahoo.com - August 4 at 8:00 PMGelesis announces additional $15M pre-order for Plenityseekingalpha.com - June 21 at 8:49 AMOver the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Studyfinance.yahoo.com - June 5 at 3:31 PMMicrobiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogelfinance.yahoo.com - June 4 at 11:34 AMGelesis Holdings, Inc. Common Stock (GLS)nasdaq.com - May 28 at 8:57 PMGelesis Holdings Inc (GLS)investing.com - May 27 at 3:51 AMGelesis to Participate in Upcoming Investor Conferencesfinance.yahoo.com - May 18 at 8:53 PMGelesis Holdings' (GLS) CEO Yishai Zohar on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 14 at 4:38 AMGelesis Holdings GAAP EPS of -$0.70, revenue of $7.51Mseekingalpha.com - May 13 at 3:22 AMGelesis to Report First Quarter 2022 Financial Results on May 12, 2022finance.yahoo.com - May 9 at 9:20 AMClinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetesfinance.yahoo.com - May 4 at 7:51 AMGelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Studyfinance.yahoo.com - April 29 at 11:03 AM Get Gelesis News Delivered to You Automatically Sign up to receive the latest news and ratings for GLS and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NYSE:GLS) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.